Search Results - "Polidorou, D."

The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital by Antoniou, C., Stefanaki, I., Stratigos, A., Avgerinou, G., Stavropoulos, P., Potouridou, I., Polidorou, D., Moustou, A.E., Kosmadaki, M., Katsambas, A.D.

“…Summary Background  Efalizumab (anti‐CD11a antibody) targets T cell‐mediated steps important in the immunopathogenesis of psoriasis. As efalizumab is intended…”
Get full text

Surgical treatment and adjuvant therapy of cutaneous melanomas (a propos of 501 cases) by Champsas, G., Chrisostomidis, C., Georgiou, P., Konofaos, P., Polidorou, D., Potouridou, I., Stratigos, A., Polizos, A., Papadopoulos, O.

Get full text